Find a Clinical Trial
Filter
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
ORCHID
Nasal polyps
All genders
18-75
Recruiting now
Department of Medicine, Division of Rheumatology
SBT777101-01
Arthritis
All genders
18-70
Recruiting now
Department of Medicine, Division of Rheumatology
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
Organogenesis Knee OA
Osteoarthritis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Assist
Chronic kidney disease
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology
RA-PROPR
Rheumatoid arthritis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology
BIPI
Systemic sclerosis
All genders
18+
Recruiting now
Department of Medicine, Division of Rheumatology